Latest Optigenex Inc (OPGX) Headlines Optigen
Post# of 3
Posted On: 03/10/2014 9:58:28 PM
Latest Optigenex Inc (OPGX) Headlines
Optigenex Inc. Reports Positive Results From a Double-Blind, Placebo Controlled Study of Onnit Labs Flagship Product, AlphaBrain(TM) With ac-11(R)
Marketwire - Tue Feb 25, 11:14AM CST
Optigenex Inc. (OTC Pink: OPGX) announced today the results of a pilot study entitled "A Proof of Concept Study for a Randomized Double-Blind, Placebo Controlled, Parallel Group, Efficacy Study of AlphaBrain(TM) administered orally," conducted by the Boston Center for Memory. The purpose of the study was to test the efficacy of AlphaBrain(TM) with ac-11(R) as an enhancer of cognitive ability, including memory, attention, problem solving and reasoning.
Optigenex Inc. Reports Positive Results From a Double-Blind, Placebo Controlled Study of Onnit Labs Flagship Product, AlphaBrain(TM) With ac-11(R)
Marketwire - Tue Feb 25, 11:14AM CST
Optigenex Inc. (OTC Pink: OPGX) announced today the results of a pilot study entitled "A Proof of Concept Study for a Randomized Double-Blind, Placebo Controlled, Parallel Group, Efficacy Study of AlphaBrain(TM) administered orally," conducted by the Boston Center for Memory. The purpose of the study was to test the efficacy of AlphaBrain(TM) with ac-11(R) as an enhancer of cognitive ability, including memory, attention, problem solving and reasoning.
(0)
(0)Optigenex Inc. (OPGX) Stock Research Links
Scroll down for more posts ▼